Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 9, 2017
Reporting Period: Third Quarter of 2017
This filing serves as a notification that the Company issued a press release on November 9, 2017, announcing its financial results for the third quarter of 2017. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The filing explicitly states that the detailed results are contained in the attached press release (Exhibit 99.1), which is not included in the input text.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific numerical comparisons or material changes versus the prior comparable period. It only confirms the announcement of Q3 2017 results.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It notes that the information in Item 2.02 and Exhibit 99.1 is "furnished" and not deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release) for actual Q3 2017 revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance metrics in the full press release.
- Check for any updated financial guidance or operational milestones mentioned in the press release.
- Confirm the status of the Company's cash position and burn rate, as these are not detailed in the 8-K cover sheet.